Venture Capital Firm Partner Scott Rocklage

The California-based 5AM Ventures firm, which offers its clients early stage investment opportunities, was founded in 2002, and Scott Rocklage joined the company the following year, then became its Managing Partner in 2004. He brought more than 3 decades of management experience to the company, having previously served as the CEO and Chairman of several healthcare companies, one of them being Cubist Pharmaceuticals, a company he was employed at from 1994 to 2003.

 

Scott Rocklage is a trained chemist who completed his studies at Berkeley’s University of California, where he received a BS degree, and at MIT, where he earned a PhD after studying under Chemistry professor Richard R. Schrock, who is known for being a Nobel Prize winner for his contributions to this field of science. Rocklage has also been given credit for being the inventor of over 30 patents in the U.S., and he’s had more than 100 peer-reviewed research papers published.

 

At 5AM Ventures, Scott Rocklage works with scientists, doctors and entrepreneurs who want to turn their ideas or inventions into medicines that will be helpful in treating the types of diseases that there is no adequate treatment for. He’s stated that the health trend he is most excited about is the one that’s aimed at researching certain types of mutations in patients. This method is used to treat cancer in an unconventional way, and it has already extended the lives of some cancer patients.

 

Scott Rocklage feels that his success in business can be credited to the fact that he is very well-organized and knows how to manage his time in a responsible manner. He encourages other business people to not be scared to take risks, and he says that he has always pushed himself to keep learning and growing. Other than working at 5AM Ventures, he is a board member at Whitehead Institute, which is a non-profit biomedical research organization.

 

When he was once asked about how 5AM Ventures got its name, he stated that it was because the company is considered to be in its early stage, and also because it deals in early stage investments.

 

Connect with Dr. Scott Rocklage on LinkedIn.

Leave a Reply

Your email address will not be published. Required fields are marked *